HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.

Abstract
Replication-competent adenovirus-mediated suicide gene therapy has proven to be safe in humans when delivered intraprostatically. Although signs of efficacy are emerging, it is likely that further improvements will be needed before this technology will have widespread applicability in the clinic. Toward this end, we have developed a second-generation, replication-competent adenovirus (Ad5-yCD/mutTK(SR39)rep-ADP) containing an improved yeast cytosine deaminase (yCD)/mutant(SR39) herpes simplex virus thymidine kinase fusion (yCD/mutTK(SR39)) gene and the adenovirus death protein (ADP) gene. Relative to the first-generation Ad5-CD/TKrep adenovirus, Ad5-yCD/mutTK(SR39)rep-ADP demonstrated greater tumor cell kill in vitro and significantly greater tumor control in preclinical models of human cancer. Quantification of transgene volume following direct injection of fadenovirus into human tumor xenografts and the naïve canine prostate demonstrated that ADP enhanced adenoviral spread in vivo. Toxicology studies were performed to determine whether the improved yCD/mutTK(SR39) fusion and ADP genes increased toxicity. Intraprostatic injection of Ad5-yCD/mutTK(SR39)rep-ADP did not result in significantly increased toxicity relative to the parental Ad5-CD/TKrep adenovirus, the latter of which has proven to be safe in two Phase I prostate cancer clinical trials. Together, these results provide the scientific basis for evaluating the safety and efficacy of the second-generation Ad5-yCD/mutTK(SR39)rep-ADP adenovirus in humans.
AuthorsKenneth N Barton, Dell Paielli, Yingshu Zhang, Sweaty Koul, Stephen L Brown, Mei Lu, John Seely, Jae Ho Kim, Svend O Freytag
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 13 Issue 2 Pg. 347-56 (Feb 2006) ISSN: 1525-0016 [Print] United States
PMID16290236 (Publication Type: Journal Article)
Chemical References
  • Adenovirus E3 Proteins
  • adenovirus death protein, Adenovirus
Topics
  • Adenovirus E3 Proteins (administration & dosage, genetics, physiology)
  • Adenoviruses, Human (genetics)
  • Animals
  • Blotting, Western
  • Cell Line, Tumor
  • Dogs
  • Genes, Transgenic, Suicide (physiology)
  • Genetic Vectors (genetics, toxicity)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Nude
  • Mice, SCID
  • Neoplasms, Experimental (pathology, therapy, virology)
  • Oncolytic Viruses (genetics, physiology)
  • Virus Replication (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: